High court OKs move to make generic Viagra

OTTAWA – The Supreme Court of Canada has granted a Canadian drug company’s challenge of the Viagra patent held by pharmaceutical giant Pfizer.

In a 7-0 decision, the court sided with Teva Canada in a case with big implications for users of erectile dysfunction drugs.

A Teva victory opens the door for the company to begin selling its owngeneric version of the drug.

In a previous Federal Court case, Teva unsuccessfully challenged Pfizer’s dominance of the erectile dysfunction drug patent.

That court rejected Teva’s request to introduce a generic version of the drug.

Pfizer’s Viagra patent expires in 2014.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.